-
17
-
-
84987566762
-
-
Abbreviations for amino acids (l-configuration unless otherwise designated) follows the recommendations of the IUPAC-IUB Commission on Biochemical Nomenclature (Eur. J. Biochem. 138 (1984) 9). Leu and L: Leucine; Trp and W: Tryptophan; Gln and Q: Glutamine; Asp: Aspartic acid; Glu: Glutamic acid. Additional abbreviation used are: AA: amino acids; Boc: tert-Butoxycarbonyl; For: Formyl; PyBOP: Benzotrazole-1-yl-oxy-tris-pyrrolidino-phosphonium hexafluorophosphate; HOBt: N-Hydroxybenzotriazloe; DIPEA: N,N-diisopropylethylamine; TFA: trifluoroacetic acid; DMF: N,N-dimethylformamide; DCM: dichloromethane; RP-HPLC: reverse-phase high performance liquid chromatography; NMR: nuclear magnetic resonance; ESI-MS: electrospray ionization-mass spectrometry.
-
Abbreviations for amino acids (l-configuration unless otherwise designated) follows the recommendations of the IUPAC-IUB Commission on Biochemical Nomenclature (Eur. J. Biochem. 138 (1984) 9). Leu and L: Leucine; Trp and W: Tryptophan; Gln and Q: Glutamine; Asp: Aspartic acid; Glu: Glutamic acid. Additional abbreviation used are: AA: amino acids; Boc: tert-Butoxycarbonyl; For: Formyl; PyBOP: Benzotrazole-1-yl-oxy-tris-pyrrolidino-phosphonium hexafluorophosphate; HOBt: N-Hydroxybenzotriazloe; DIPEA: N,N-diisopropylethylamine; TFA: trifluoroacetic acid; DMF: N,N-dimethylformamide; DCM: dichloromethane; RP-HPLC: reverse-phase high performance liquid chromatography; NMR: nuclear magnetic resonance; ESI-MS: electrospray ionization-mass spectrometry.
-
-
-
-
18
-
-
76349116085
-
-
Experimental conditions: Synthesis was performed in a 10 mL peptides synthesizer, starting with 110 mg Boc-Trp(For)-PAM resin (loading 0.6 mmol/g) by the standard Boc protocol. The peptide chain was then assembled by consecutive addition of the alternating 5 eq Boc-d-Leu-OH, 3 eq Boc-Trp-OH and 1 eq Boc-Gln-OH according to the PyBOP coupling procedure: 4 eq Boc-amino acid, 4 eq PyBOP, 4 eq HOBt and 8 eq DIPEA in pure DMF for 30 min activation time and 30 min reaction time. Completion of the reaction was monitored by the ninhydrin test. Boc protecting groups were removed by treatment with TFA (50, v/v in DCM; 15 min; twice, followed by the conventional washing cycles with DCM and DMF. When the last residue was coupled, the For protecting group was subsequently removed by treatment with piperidine 20, v/v in DMF; 10 min; twice, After being washed well with DCM five times and dried under reduced pressure to remove DCM residues, the resin was treated with 10 mL HF and 5% p-methyl phen
-
Experimental conditions: Synthesis was performed in a 10 mL peptides synthesizer, starting with 110 mg Boc-Trp(For)-PAM resin (loading 0.6 mmol/g) by the standard Boc protocol. The peptide chain was then assembled by consecutive addition of the alternating 5 eq Boc-d-Leu-OH, 3 eq Boc-Trp-OH and 1 eq Boc-Gln-OH according to the PyBOP coupling procedure: 4 eq Boc-amino acid, 4 eq PyBOP, 4 eq HOBt and 8 eq DIPEA in pure DMF for 30 min activation time and 30 min reaction time. Completion of the reaction was monitored by the ninhydrin test. Boc protecting groups were removed by treatment with TFA (50%, v/v in DCM; 15 min; twice), followed by the conventional washing cycles with DCM and DMF. When the last residue was coupled, the For protecting group was subsequently removed by treatment with piperidine (20%, v/v in DMF; 10 min; twice). After being washed well with DCM five times and dried under reduced pressure to remove DCM residues, the resin was treated with 10 mL HF and 5% p-methyl phenol at 0 °C for 1 h. The crude product of decapeptides was extracted in aqueous acetic acid (50%, v/v) and lyophilized. Semi-preparative RP-HPLC was employed to remove by-products.
-
-
-
-
19
-
-
76349094715
-
-
Experimental conditions: The decapeptides, with a purity of over 99, was cyclized by treatment with 5 eq PyBOP and 10 eq DIPEA in pure DMF at room temperature for 24 h. The endpoint of reaction was determined by analytic RP-HPLC (Fig. 2) and the same of water was added to quench the reaction. The crude product was purified by semi-preparative RP-HPLC and the target cyclic peptide was obtained by lyophilization as a white powder with a yield of 30-35% and HPLC purity of over 98, The cyclic peptide was identified by ESI-MS (Fig. 3) and 1H NMR. ESI-MS: [M+H, 1440.3, M+H++K+]2, 739.4. 1H NMR (DMSO-d6, δ 0.65 (d, 30H, 1.0-1.5 (m, 15H, 1.70-2.24 (m, 4H, 2.18-3.28 (m, 10H, 4.0-4.8 (m, 12H, 6.85-7.32 (m, 16H, 7.55-7.62 (m, 4H, 7.76-8.44 (m, 8H, 10.79 s, 4H
-
6): δ 0.65 (d, 30H), 1.0-1.5 (m, 15H), 1.70-2.24 (m, 4H), 2.18-3.28 (m, 10H), 4.0-4.8 (m, 12H), 6.85-7.32 (m, 16H), 7.55-7.62 (m, 4H), 7.76-8.44 (m, 8H), 10.79 (s, 4H).
-
-
-
|